Sumitomo Mitsui Trust Group Inc. Trims Stock Holdings in Humana Inc. $HUM

Sumitomo Mitsui Trust Group Inc. cut its holdings in shares of Humana Inc. (NYSE:HUM) by 8.4% during the first quarter, HoldingsChannel.com reports. The fund owned 324,773 shares of the insurance provider’s stock after selling 29,651 shares during the quarter. Sumitomo Mitsui Trust Group Inc.’s holdings in Humana were worth $56,312,000 as of its most recent filing with the Securities and Exchange Commission.

Several other institutional investors and hedge funds have also recently bought and sold shares of HUM. Montag A & Associates Inc. boosted its stake in Humana by 1,880.0% during the 4th quarter. Montag A & Associates Inc. now owns 99 shares of the insurance provider’s stock worth $25,000 after purchasing an additional 94 shares during the period. CoreCap Advisors LLC boosted its stake in shares of Humana by 54.4% during the fourth quarter. CoreCap Advisors LLC now owns 105 shares of the insurance provider’s stock worth $27,000 after buying an additional 37 shares during the period. Fideuram Asset Management Ireland dac purchased a new position in shares of Humana during the fourth quarter worth about $27,000. Reflection Asset Management acquired a new position in Humana in the 4th quarter valued at about $29,000. Finally, Rosenberg Matthew Hamilton raised its stake in Humana by 136.0% during the 4th quarter. Rosenberg Matthew Hamilton now owns 118 shares of the insurance provider’s stock valued at $30,000 after acquiring an additional 68 shares during the last quarter. Hedge funds and other institutional investors own 92.38% of the company’s stock.

Wall Street Analysts Forecast Growth

Several research analysts have weighed in on the company. Royal Bank Of Canada lifted their target price on Humana from $246.00 to $415.00 and gave the company a “sector perform” rating in a research note on Thursday. Evercore lifted their price objective on shares of Humana from $250.00 to $370.00 in a research report on Thursday, June 11th. Oppenheimer upgraded shares of Humana from an “outperform” rating to an “outperform” rating in a research report on Wednesday, May 20th. Robert W. Baird lowered their target price on shares of Humana from $264.00 to $205.00 and set a “neutral” rating on the stock in a report on Wednesday, April 15th. Finally, Wells Fargo & Company cut shares of Humana from a “cautious” rating to a “reduce” rating in a report on Wednesday, May 20th. One investment analyst has rated the stock with a Strong Buy rating, eight have assigned a Buy rating, sixteen have assigned a Hold rating and three have given a Sell rating to the company. According to data from MarketBeat, Humana presently has a consensus rating of “Hold” and an average price target of $303.74.

Humana Price Performance

Shares of NYSE HUM traded down $5.00 during trading on Friday, hitting $392.76. 1,788,183 shares of the company were exchanged, compared to its average volume of 1,385,265. The company has a debt-to-equity ratio of 0.66, a current ratio of 1.77 and a quick ratio of 1.77. Humana Inc. has a 1 year low of $163.11 and a 1 year high of $415.00. The company has a market cap of $47.16 billion, a price-to-earnings ratio of 42.01, a PEG ratio of 2.24 and a beta of 0.71. The firm’s fifty day moving average price is $338.80 and its 200 day moving average price is $255.19.

Humana (NYSE:HUM) last announced its quarterly earnings results on Wednesday, April 29th. The insurance provider reported $10.31 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $9.97 by $0.34. Humana had a net margin of 0.82% and a return on equity of 10.45%. The business had revenue of $39.65 billion during the quarter, compared to the consensus estimate of $39.37 billion. During the same quarter last year, the firm posted $11.58 EPS. The business’s revenue was up 23.5% compared to the same quarter last year. Humana has set its FY 2026 guidance at 9.000- EPS. On average, sell-side analysts expect that Humana Inc. will post 9.03 earnings per share for the current fiscal year.

Humana Announces Dividend

The business also recently announced a quarterly dividend, which will be paid on Friday, July 31st. Shareholders of record on Friday, June 26th will be issued a $0.885 dividend. The ex-dividend date of this dividend is Friday, June 26th. This represents a $3.54 dividend on an annualized basis and a yield of 0.9%. Humana’s dividend payout ratio (DPR) is 37.86%.

About Humana

Humana Inc (NYSE: HUM) is a health insurance company headquartered in Louisville, Kentucky, that primarily serves individuals and groups across the United States. The company is best known for its Medicare business, offering Medicare Advantage plans and prescription drug (Part D) coverage, alongside a range of commercial and employer-sponsored group health plans. Humana’s products are designed to cover medical, behavioral health and pharmacy needs for members, with particular emphasis on seniors and Medicare-eligible populations.

In addition to traditional insurance products, Humana provides care-management and wellness services intended to support chronic-condition management, preventive care and care coordination.